Sanofi SA Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175

11:39 EDT 29 Sep 2018 | BioPortfolio Report Blog

Sanofi SA Strategy, SWOT and Corporate Finance Report


Sanofi SA Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.

Key Highlights

Sanofi SA Sanofi or the group' is a Francebased international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. In addition, it provides prescription products, consumer healthcare products, generics, and vaccines. It offers products related to Vaccines that include pediatric vaccines for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b Hib, influenza vaccines and adult and adolescent booster vaccines. The group operates across North America and Europe. Sanofi is headquartered in Paris, France.


Detailed information on Sanofi SA required for business and competitor intelligence needs

A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis

An indepth view of the business model of Sanofi SA including a breakdown and examination of key business segments

Intelligence on Sanofi SA's mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Sanofi SA, such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Sanofi SA and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Sanofi SA as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Sanofi SA's business structure, strategy and prospects.

Original Article: Sanofi SA Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175


More From BioPortfolio on "Sanofi SA Strategy, SWOT and Corporate Finance Report [Report Updated: 28082018] Prices from USD $175"

Quick Search


Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...